Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904
- Citation:
- J Clin Oncol vol 27 (33) 5506-5512
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA031946, U10 CA033601, CA31946, CA33601
- Corr. Author:
- Authors:
- Matthew H. Kulke Margaret A. Tempero Donna Niedzwiecki Donna R. Hollis Hedy L. Kindler Michael Cusnir Peter C. Enzinger Stefan M. Gorsch Richard M. Goldberg Robert J. Mayer
- Networks:
- Study
- CALGB-89904
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Gic26, Original Reports, Gastrointestinal Cancer